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Abstract Certain picornaviruses encode proteinases which
cleave the translation initiation factor eIF4G, a member of the
eIF4F complex which recruits mRNA to the 40S ribosomal
subunit during initiation of protein synthesis in eukaryotes. We
have compared the efficiency of eIF4G cleavage in rabbit
reticulocyte lysates during translation of mRNAs encoding the
foot-and-mouth disease virus leader proteinase (Lpro) or the
human rhinovirus 2Apro. Under standard translation conditions,
Lpro cleaved 50% of eIF4G within 4 min after initiation of protein
synthesis, whereas 2Apro required 15 min. At these times, the
molar ratios of proteinase to eIF4G were 1:130 for Lpro and 1:12
for 2Apro, indicating a much more efficient in vitro cleavage than
previously observed. The molar ratios are similar to those
observed during viral infection in vivo. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Members of the eIF4 (eukaryotic initiation factor) group of
initiation factors play a central role in the initiation of protein
synthesis in eukaryotes [1]. These factors comprise the cap
binding protein eIF4E, the RNA helicase eIF4A, the RNA
binding protein eIF4B and the adapter protein eIF4G. In
mammalian systems, eIF4E, eIF4A and eIF4G can be isolated
as a complex designated eIF4F. eIF4F, together with eIF4B
and eIF3, recognise the cap structure at the 5P end of the
cellular mRNA, unwind RNA secondary structure in an
ATP-dependent manner and enable binding of the 40S ribo-
somal subunit to the mRNA [2^4].
The eIF4F complex is an important control point for the
overall rate of protein synthesis [5]. During the replication of
certain picornaviruses such as foot-and-mouth disease virus
(FMDV), human rhino- (HRV) and entero-viruses, transla-
tion of capped cellular mRNA in the infected cell is shut
down by speci¢c cleavage of eIF4G [6^8]. Initiation of protein
synthesis from viral mRNA is una¡ected as it initiates inter-
nally and does not require a cap structure [9,10]. Substantial
biochemical and genetic evidence shows that the papain-like
leader proteinase (Lpro) of FMDV and the chymotrypsin-like
2A proteinases (2Apro) of HRVs and enteroviruses cleave
eIF4G [11^14]. Indeed, the cleavage sites of the enzymes on
eIF4G have been determined; they are separated by six amino
acids [15,16]. Despite this knowledge, the mechanism of this
cleavage is still in dispute. Using puri¢ed eIF4F and recombi-
nant proteinases, several groups have demonstrated that
eIF4G can be cleaved directly in vitro [12,14,16,17]. However,
the proteinase concentration present in the infected cell at the
time of eIF4G cleavage is much lower than the amount of
proteinase required for eIF4G cleavage in vitro [13,18,19].
This has led to the suggestion that the picornaviral protein-
ases may activate latent cellular proteinases which then am-
plify the response [20,21]. This view has been strengthened, at
least for poliovirus, by the observation that the majority of
the eIF4G cleaving activity isolated from infected cells does
not appear to co-purify with 2Apro containing fractions [22].
Based on the observations that HRV2 2Apro cleaves eIF4G
bound to eIF4E more e⁄ciently than eIF4G alone [17] and
that most of the eIF4G in actively translating rabbit reticulo-
cyte lysates (RRLs) is both complexed to eIF4E and bound to
ribosomes [23], we reasoned that cleavage of eIF4G may oc-
cur during synthesis of the picornaviral proteinases. The spa-
tial proximity of the nascent proteinase, which is synthesised
on the ribosome, and eIF4G, which is bound to the ribosome
via eIF3, could be bene¢cial to the cleavage reaction. To in-
vestigate this, we examined and quanti¢ed the cleavage of
endogenous eIF4G in rabbit reticulocyte lysates during syn-
thesis of picornaviral proteinases. We present here a study of
the kinetics of eIF4G cleavage by FMDV Lpro from serotype
O1k and by HRV2 2Apro.
2. Materials and methods
2.1. Plasmids
The plasmid pet8cFMDV Lbpro (encoding the mature Lbpro) con-
tains the FMDV nucleotides 892^1413 of the FMDV O1k cDNA [24]
followed by two stop codons, cloned into the NcoI and BamHI re-
striction sites of the T7 polymerase expression vector pET8c (Nova-
gen). The plasmid pet8cFMDV LbproVP4VP2 (encoding the mature
Lbpro, all of VP4 and 78 amino acids of VP2) contains the FMDV
nucleotides 892^1896 followed by two stop codons similarly cloned
into pet8c [16]. In pet8cFMDV LbproC51A VP4VP2, the active site
cysteine 51 is replaced by an alanine. The plasmid pet8cHRV2 2Apro
has been previously described [12]. It contains the HRV2 nucleotides
3161^3586 encoding the mature 2Apro followed by two stop codons.
Thus, all mRNAs produced from the above plasmids have the same
sequence at the 5P untranslated region.
2.2. In vitro transcription and translation
Plasmids pet8cFMDV Lbpro and pet8cHRV2 2Apro (2^5 Wg) were
linearised with BamHI; plasmids pet8cFMDV LbproVP4VP2 and
pet8cFMDV LbproC51A VP4VP2 were linearised with SalI (FMDV
nucleotide 1712; see Fig. 2A). In vitro transcription was as described
[12]. RNA concentrations were quanti¢ed by OD260 measurement and
con¢rmed by electrophoresis on a 1% agarose gel containing 0.1%
sodium dodecyl sulfate.
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In vitro translation reactions (typically 50 Wl) contained 70% RRL
(Promega), 21 WCi [35S]Met/Cys label (1170 mCi/mmol, American
Research Company), amino acids (except methionine) at 20 WM and
the RNA as indicated. After preincubation for 2 min at 30‡C, trans-
lation was started by addition of RNA. Aliquots (10 Wl) were removed
at the designated time points and the reaction was stopped by imme-
diate transfer to ice, the addition of unlabelled methionine and cys-
teine to a ¢nal concentration of 2 mM and Laemmli sample bu¡er.
2.3. Electrophoresis and immunoblotting
The polyacrylamide gel electrophoresis system described by Dasso
and Jackson [25] was used for analysis of both translation products
and the state of eIF4G. Aliquots (2 Wl for translation products and
3 Wl for immunoblotting) were diluted with sample bu¡er and sub-
jected to gel electrophoresis on 15% and 6% gels, respectively. The
15% gels were £uorographed by incubation for 30 min in 1 M sodium
salicylate (dissolved in 45% methanol) and exposed after drying on
Kodak Biomax MR ¢lm. Immunoblotting and detection of eIF4G
with the anti-eIF4G peptide 7 antiserum [26] was as described [27],
except that Immobilon-P membranes (Millipore) were used and that
the second antibody (anti-rabbit IgG coupled to alkaline phosphatase)
was from Sigma.
2.4. Quanti¢cation of protein synthesis
Radioactivity was counted in the dried polyacrylamide gels using an
Instant Imager (Canberra Packard); the counting e⁄ciency was de-
termined to be 65% by counting known amounts of [35S]Met/Cys label
spotted onto a dried gel. The amounts of proteinase synthesised were
calculated as follows (all amounts are given per Wl of ¢nal translation
reaction): 5 pmol unlabelled methionine (contributed by the endoge-
nous methionine in the lysate itself, as stated by the manufacturer)
and 22 pmol cysteine (2 pmol endogenous and 20 pmol from the
amino acid mix) were present in the translation reaction. The addition
of 0.42 WCi [35S]Met/Cys label (70% methionine, 25% cysteine and 5%
other) at 1170 Ci/mmol adds 0.25 pmol methionine and 0.09 pmol
cysteine to the reaction. Thus, in 1 Wl translation reaction, 5.25 pmol
of methionine and 22.09 pmol of cysteine were present. Taking into
account the counting e⁄ciency and the reference data, a total of
255 300 cpm were present per Wl. Allowing for the distribution of
the radioactivity between the methionine (75%) and cysteine (25%),
5.25 pmol methionine and 22.09 pmol of cysteine correspond to
191 500 and 63 800 cpm, respectively. The Lbpro has three methionines
and two cysteines; as methionine is limiting, a maximum of 1.75 pmol
(191 500 cpm) of Lbpro per Wl can be synthesised. This amount of
Lbpro contains 3.5 pmol of cysteine, corresponding to 10 100 cpm.
Thus, 1.75 pmol Lbpro represents in total 201 600 cpm; the speci¢c
radioactivity of Lbpro is therefore 115 cpm/fmol (19.8 pg, MW Lbpro
19 800). For HRV2 2Apro (three methionines and seven cysteines), a
maximum of 1.75 pmol/Wl can also be synthesised, with concomitant
incorporation of 12.25 pmol cysteine (35 400 cpm). Thus, 1.75 pmol
HRV2 2Apro represent in total 226 900 cpm; the speci¢c radioactivity
of HRV2 2Apro is therefore 129 cpm/fmol (16.3 pg, MW 2Apro
16 300).
3. Results
3.1. Cleavage of eIF4G during in vitro protein synthesis of
FMDV Lpro
Lpro is the ¢rst protein encoded on the FMDV genome. As
protein synthesis initiates from one of two AUG codons, two
forms of Lpro, Labpro and Lbpro, can be generated [28]. Both
forms have the same enzymatic activities [29]. Based on evi-
dence that the 28 amino acid shorter Lbpro form is the bio-
logically relevant one [30], we have investigated this form.
Fig. 1A shows the synthesis of FMDV Lbpro in RRLs pro-
grammed with an uncapped mRNA encoding the mature pro-
teinase followed by two stop codons. Synthesis of Lbpro was
detectable after 4 min. The concentration of Lbpro reached
(see Section 2) at a given time point is indicated underneath
the respective lane (Fig. 1A).
To investigate the state of eIF4G in these reactions, ali-
quots of the translation mixture were blotted onto an Immo-
bilon-P membrane and probed with an antiserum to the
N-terminus of eIF4G. Intact eIF4G is observed as a series
of bands with an apparent molecular weight around
220 kDa. Cleavage by the Lbpro gives rise to a similar series
of bands migrating with an apparent molecular weight be-
tween 150 and 120 kDa (Fig. 1B), although the calculated
molecular weight is only 80 kDa. These are the N-terminal
cleavage products, designated cpN [12,15]. Clearly, the cleav-
age of eIF4G is extraordinarily e⁄cient in this system. After
4 min, approximately 50% of the eIF4G had been cleaved; the
concentration of Lbpro at this time had risen to 15 pg/Wl (0.76
nM). Essentially complete eIF4G cleavage was observed after
8 min. No cleavage of the eIF4G was observed in lysates
lacking RNA (Fig. 1B).
3.2. Cleavage of eIF4G during in vitro protein synthesis of
FMDV LproVP4VP2
To investigate whether similar kinetics of eIF4G cleavage
are observed when Lbpro processes itself from the growing
polypeptide chain as it does in vivo, we programmed RRLs
Fig. 1. Kinetics of eIF4G cleavage during in vitro translation of
Lbpro from the mRNA FMDV Lbpro. RRLs were incubated with or
without the uncapped mRNA FMDV Lbpro (7 ng/Wl) as described
in Section 2; protein synthesis was terminated at the times given by
placing the samples on ice followed by the addition of unlabelled
methionine and cysteine to 2 mM and Laemmli sample bu¡er. Ali-
quots (2 and 3 Wl, respectively) were analysed on 15% polyacryl-
amide gels followed by £uorography for the synthesis of Lpro (A)
and on 6% polyacrylamide gels followed by immunoblotting for the
status of eIF4G (B). The position of the Lbpro is marked in A; the
concentration (in pg/Wl) of Lbpro reached at each time point is indi-
cated underneath the lane. In B, intact eIF4G and the cleavage
product cpN are marked. Protein standards (in kDa) are indicated
in both panels.
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with uncapped RNA transcribed from pet8cFMDV
LbproVP4VP2 cut with SalI (Fig. 2A). This mRNA encodes
the mature Lbpro sequence followed by VP4 and 23 amino
acids of VP2. The Lbpro processes itself from the growing
polypeptide chain by cleavage between its own C-terminus
and the N-terminus of VP4 (Fig. 2A). The mRNA concen-
tration was adjusted so that the rate of protein synthesis was
as close as possible to that in Fig. 1 (compare Fig. 1A with
Fig. 2B, middle panel). Two further mRNA concentrations
were also included to investigate whether the cleavage e⁄-
Table 1
E⁄ciency of eIF4G cleavage by Lbpro and 2Apro
RNA 50% eIF4G cleavage at (min)a Proteinase concentration at 50% eIF4G cleavage Approximate molar ratio
proteinase:eIF4Gb
pg/Wl nM
FMDV Lbpro 4 15 0.76 1:130
FMDV LbproVP4VP2
0.25U 8 14 0.71 1:130
1U 4 16 0.81 1:130
4U 94 9 30 9 1.52 v 1:66
HRV2 2Apro 15 137 8.4 1:12
aSimilar results were obtained in ¢ve separate experiments for Lbpro and LbproVP4VP2 and two for 2Apro.
bThe concentration of eIF4G in RRLs was estimated as 0.1 WM, using data from Rau et al. [23] and Borman et al. [27].
Fig. 2. Kinetics of eIF4G cleavage during in vitro translation of Lbpro from the mRNA FMDV LbproVP4VP2. The structure of the expression
block of pet8cFMDV LproVP4VP2 is shown in A. After cleavage with SalI, uncapped mRNA was transcribed and used at a concentration of
4.2 ng/Wl to program protein synthesis (B, panel 1U) as described in Fig. 1. In addition, two further mRNA concentrations were tested, 1.1
ng/Wl (B, panel 0.25U) and 16.8 ng/Wl (B, panel 4U). The mRNA FMDV LproC51A VP4VP2 (9 ng/Wl) encoding the inactive LbproC51A
VP4VP2 was also used to program RRLs. Analysis of the synthesis of Lbpro (B) and the cleavage of eIF4G (C) was as in Fig. 1. The positions
of the Lbpro, the cleaved product VP4VP2 and the uncleaved LproVP4VP2 are marked in B; the concentration (in pg/Wl) of Lbpro reached at
each time point is indicated underneath the lane. Note that in part B, the middle and right panels are overexposed in order to visualise the
translation products in the left panel.
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ciency was a¡ected by the rate of translation (Fig. 2B, left and
right panels).
Synthesis of the mature Lbpro was detectable after 4 min in
all three reactions and continued to rise over the periods in-
vestigated (Fig. 2B). As the amount of uncleaved LproVP4VP2
remained very low, even at later time points, self-processing
was very e⁄cient. The rate of Lbpro synthesis increased with
increasing concentration of the mRNA. Nevertheless, in each
experiment, 50% of cleavage of eIF4G had occurred when a
concentration of 14^30 pg/Wl Lbpro had been reached (Fig.
2C). This corresponds to the 8 min time point in the lowest
mRNA concentration, and the 4 min time points for the two
higher mRNA concentrations (Fig. 2C). In contrast, when
protein synthesis was initiated with the mutant mRNA
FMDV LbproC51A VP4VP2, neither processing of the Lbpro
from the VP4VP2 protein nor cleavage from eIF4G was ob-
served, demonstrating that the observed proteolytic reactions
were dependent on an active Lbpro.
Table 1 summarises the results from both experiments and
gives the molar ratios of proteinase to eIF4G. The eIF4G
concentration in RRLs was estimated from data from Rau
et al. [23] and Borman et al. [27] to be 0.1 WM. Clearly, there
is no di¡erence in the cleavage of eIF4G when the RRLs were
programmed to synthesise the same amounts of Lbpro or
LbproVP4VP2 (Table 1, compare Lbpro with LbproVP4VP2,
mRNA concentration 1U). Thus, e⁄cient cleavage of
eIF4G by the Lbpro occurs whether or not the proteinase
must process itself from the growing polypeptide chain. In
addition, the same kinetics were also obtained when the trans-
lation was driven by the EMCV internal ribosome entry site
(data not shown), indicating that the reaction is not depen-
dent on the mode of protein synthesis initiation.
3.3. Cleavage of eIF4G during protein synthesis of HRV2 2Apro
eIF4G is also processed during the replication of human
entero- and rhinoviruses by the proteinase designated 2Apro.
To investigate whether the cleavage of eIF4G by 2Apro during
in vitro protein synthesis had similar kinetics to cleavage by
the FMDV Lbpro, RRLs were programmed with the mRNA
HRV2 2Apro, which encodes the mature proteinase followed
by two stop codons. Protein synthesis and the state of eIF4G
were examined (Fig. 3A,B). The eIF4G cleavage kinetics of
HRV2 2Apro are di¡erent from those of Lbpro, even though
the rate of synthesis of the two proteinases was similar (com-
pare Fig. 1A, 12 min time point and Fig. 3A, 10 min time
point). After 10 min, only about 20% of the eIF4G had been
cleaved, although the concentration of HRV2 2Apro had
reached 79 pg/Wl (4.85 nM). 50% cleavage was obtained after
15 min (Fig. 3B), when the concentration of 2Apro was 137 pg/
Wl (8.4 nM). This represents a molar ratio of 2Apro to eIF4G
of 1:12 (Table 1).
4. Discussion
The data presented here show that the cleavage of eIF4G
during synthesis of FMDV Lbpro and HRV2 2Apro can be
extremely e⁄cient. The reaction occurs rapidly at low molar
ratios of proteinase to eIF4G, similar to those calculated to be
found during in vivo replication [13]. In addition, the rate of
the reaction is higher and the molar ratios of proteinase to
eIF4G are much lower than those found when pure prepara-
tions of proteinases are incubated with puri¢ed preparations
of eIF4G, eIF4G and eIF3, or when HeLa cell extracts are
used as a source of eIF4F [12,13,16,17]. For example, in ex-
periments using puri¢ed poliovirus 2Apro and a puri¢ed com-
plex of eIF4F/eIF3, a molar ratio of proteinase to eIF4G of
2.5:1 was required to obtain 50% cleavage of eIF4G over a 2
h period [13].
Two di¡erences are apparent in the kinetics of cleavage
between the two proteinases. Firstly, the Lbpro concentration
required for 50% eIF4G cleavage is signi¢cantly lower than
that required by 2Apro. Secondly, the onset of cleavage by
Lbpro is more rapid. This suggests that Lbpro folds and be-
comes active either during or immediately after its synthesis,
whereas 2Apro requires some time to reach its active state. As
2Apro needs a zinc ion for its structural integrity, the enzyme
may require longer to fold correctly [31,32]. These di¡erences
may explain why in vivo cleavage of eIF4G during FMDV
replication occurs earlier (1^1.5 h post infection (p.i.)) than in
enteroviruses (2 and 3 h p.i. for poliovirus and coxsackievirus,
respectively) and HRVs (3^4 h p.i.) [13,16].
Why is the eIF4G cleaved so e⁄ciently in this system?
Firstly, in actively translating ribosomes in RRLs, most of
the eIF4G has been shown to be complexed with eIF4E and
with the ribosomes [23]. As the complex of eIF4G and eIF4E
has been demonstrated to be a better substrate for HRV2
2Apro than eIF4G itself [17], this could promote eIF4G cleav-
age. Secondly, the synthesis of a viral proteinase on the ribo-
some brings it into close proximity with ribosome bound
eIF4G, possibly increasing the interaction between enzyme
and substrate, and thus further enhancing eIF4G cleavage.
For a picornaviral infection, therefore, this implies that the
Fig. 3. Kinetics of eIF4G cleavage during in vitro translation of
HRV2 2Apro. Protein synthesis from the uncapped mRNA HRV2
2Apro (15 ng/Wl) was as described in Fig. 1, as was the analysis of
the synthesis of 2Apro (A) and the cleavage of eIF4G (B). The con-
centration (in pg/Wl) of 2Apro reached at each time point is indicated
underneath the lane.
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cleavage of eIF4G can occur during the initial phase of pro-
tein synthesis from the newly replicated viral RNA, before
detectable amounts of the viral proteins are present.
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